These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12494466)
1. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. Winnett G; van Hagen D; Schrey M Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466 [TBL] [Abstract][Full Text] [Related]
2. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. Liu JD; Tsai SH; Lin SY; Ho YS; Hung LF; Pan S; Ho FM; Lin CM; Liang YC Life Sci; 2004 Mar; 74(19):2451-63. PubMed ID: 14998722 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R; Iñiguez MA; Fresno M Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320 [TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507 [TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079 [TBL] [Abstract][Full Text] [Related]
7. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells. Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296 [TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. Katura T; Moriya T; Nakahata N Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036 [TBL] [Abstract][Full Text] [Related]
9. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Rubin GL; Zhao Y; Kalus AM; Simpson ER Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129 [TBL] [Abstract][Full Text] [Related]
11. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. Emi M; Maeyama K Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841 [TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Kim EH; Surh YJ Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499 [TBL] [Abstract][Full Text] [Related]
14. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma. Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149 [TBL] [Abstract][Full Text] [Related]
16. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150 [TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Paumi CM; Wright M; Townsend AJ; Morrow CS Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885 [TBL] [Abstract][Full Text] [Related]
18. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150 [TBL] [Abstract][Full Text] [Related]
19. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. Olmos G; Conde I; Arenas I; Del Peso L; Castellanos C; Landazuri MO; Lucio-Cazana J Cell Signal; 2007 Oct; 19(10):2098-105. PubMed ID: 17658243 [TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Kim HJ; Kim JY; Meng Z; Wang LH; Liu F; Conrads TP; Burke TR; Veenstra TD; Farrar WL Cancer Res; 2007 Mar; 67(6):2595-602. PubMed ID: 17363578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]